retatrutide phase 2 results weight loss of a new medication, Retatrutide, showed the highest amount of in a clinical trial so far. 24% of body weight lost. An average of 58 pounds over 48 weeks! The medical management of Retatrutide Phase 2 NEJM Trial:

Description

Key Takeaways MedVi charges $199$299/month for compounded GLP-1 medications through its online telehealth platform, with no insurance accepted Several alternatives cost less: Enhance.MD starts at $49 for the first month, Yucca Health from $169/month, and T-Mates offers no-hidden-fee flat pricing Insurance-friendly options exist: Found Health (free insurance check) and PlushCare work with health insurance, potentially saving $50$200+/month All providers offer compounded or brand-name GLP-1s: Semaglutide and tirzepatide are the most commonly prescribed across platforms Research-grade peptides offer another path: For laboratory and research use, GLP-1 compounds are available at significantly lower cost MedVi has grown into one of the more visible telehealth platforms for GLP-1 weight loss prescriptions, serving over 500,000 patients through its online portal and generating $1.6 billion in first-year sales

Second Nature Second Nature charges an all-inclusive monthly fee covering medication, delivery, dietitian coaching, app access, and peer support: Wegovy programme: ~99-249 per month depending on dose Mounjaro programme: pricing available on the Second Nature website Non-medication programme: from 33/month WeightWatchers WeightWatchers UK GLP-1 programme is a membership fee for the behavioural support only

After adding into the ELISA wells, incubate for 15min at 37C in dark.) Due to different assay environments and operations, assay data below and standard curve are provided for reference